Product News: OxyContin

Share this article:
FDA approved a new formulation of OxyContin, an opoid analgesic manufactured by Purdue Pharma. The new formulation aims to stem abuse of the drug by making it more difficult to cut, break or crush the pill.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.